These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23565491)

  • 21. The regulation of AMP-activated protein kinase by upstream kinases.
    Carling D; Sanders MJ; Woods A
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S55-9. PubMed ID: 18719600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females.
    Steinberg GR; Smith AC; Van Denderen BJ; Chen Z; Murthy S; Campbell DJ; Heigenhauser GJ; Dyck DJ; Kemp BE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4575-80. PubMed ID: 15356065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMP-activated protein kinase: balancing the scales.
    Carling D
    Biochimie; 2005 Jan; 87(1):87-91. PubMed ID: 15733742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of skeletal muscle leptin response does not precede the exercise-induced recovery of insulin-stimulated glucose uptake in high-fat-fed rats.
    Ritchie IR; Gulli RA; Stefanyk LE; Harasim E; Chabowski A; Dyck DJ
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R492-500. PubMed ID: 21084675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.
    Haque MS; Minokoshi Y; Hamai M; Iwai M; Horiuchi M; Shimazu T
    Diabetes; 1999 Sep; 48(9):1706-12. PubMed ID: 10480598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipose tissue as an endocrine organ.
    Ahima RS
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of leptin in the regulation of lipid and carbohydrate metabolism].
    Gogga P; Karbowska J; Meissner W; Kochan Z
    Postepy Hig Med Dosw (Online); 2011 Apr; 65():255-62. PubMed ID: 21677350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
    Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
    Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models.
    Yau SW; Henry BA; Russo VC; McConell GK; Clarke IJ; Werther GA; Sabin MA
    Endocrinology; 2014 Jun; 155(6):2133-43. PubMed ID: 24654786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver.
    Wein S; Ukropec J; Gasperíková D; Klimes I; Seböková E
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):244-51. PubMed ID: 17479441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipokines in Healthy Skeletal Muscle and Metabolic Disease.
    Coles CA
    Adv Exp Med Biol; 2016; 900():133-60. PubMed ID: 27003399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.
    Tanaka T; Hidaka S; Masuzaki H; Yasue S; Minokoshi Y; Ebihara K; Chusho H; Ogawa Y; Toyoda T; Sato K; Miyanaga F; Fujimoto M; Tomita T; Kusakabe T; Kobayashi N; Tanioka H; Hayashi T; Hosoda K; Yoshimatsu H; Sakata T; Nakao K
    Diabetes; 2005 Aug; 54(8):2365-74. PubMed ID: 16046303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nesfatin-1 activates lipid mobilization in adipose tissue and fatty acid oxidation in muscle via the sympathetic nervous system.
    Liu Y; Chen X; Qu Y; Song L; Lin Q; Li M; Su K; Li Y; Dong J
    Biofactors; 2020 May; 46(3):454-464. PubMed ID: 31898375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
    Gaidhu MP; Fediuc S; Ceddia RB
    J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AMPK and the neuroendocrine regulation of appetite and energy expenditure.
    Stark R; Ashley SE; Andrews ZB
    Mol Cell Endocrinol; 2013 Feb; 366(2):215-23. PubMed ID: 22789749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle AMP kinase as a target to prevent pathogenesis of Type 2 diabetes.
    Krook A; Long YC; Zierath JR
    Expert Rev Endocrinol Metab; 2007 Jul; 2(4):477-485. PubMed ID: 30290427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.
    Yu X; McCorkle S; Wang M; Lee Y; Li J; Saha AK; Unger RH; Ruderman NB
    Diabetologia; 2004 Nov; 47(11):2012-21. PubMed ID: 15578153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
    Cha SH; Hu Z; Chohnan S; Lane MD
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic AMPK as a Mediator of Hormonal Regulation of Energy Balance.
    Wang B; Cheng KK
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.